Unrecognized Primary Hypoparathyroidism with Severe Hypocalcemia in the Presence of COVID-19 Infection

被引：3
|
作者：
Grigoravicius, Domas [1 ]
Siauliene, Laura [1 ,2 ]
Visockiene, Zydrune [1 ,2 ]
机构：
[1] Vilnius Univ, Inst Clin Med, Fac Med, LT-03101 Vilnius, Lithuania
[2] Vilnius Univ Hosp Santaros Klin, Santariskiq Str 2, LT-08661 Vilnius, Lithuania
来源：
ACTA MEDICA LITUANICA | 2022年 / 29卷 / 01期
关键词：
primary hypoparathyroidism; hypocalcemia; COVID-19; EPIDEMIOLOGY;
D O I：
10.15388/Amed.2021.29.1.9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Primary hypoparathyroidism (PHPT) is a rare disease most commonly caused by surgical parathyroid glands destruction or genetic disorders. PHPT manifestation varies from subclinical to acute or even lethal symptoms. In atypical presentation the signs of hypocalcemia could be missed, and asymptotic chronic hypocalcemia could manifest only in the presence of exacerbated comorbidities, infections, hypomagnesemia or certain medications. We present a case of PHPT with severe hypocalcemia manifesting as seizures and delirium in a presence of COVID-19 infection.
引用
收藏
页码：136 / 143
页数：8
相关论文
共 50 条
  • [21] Laboratory and genetic predictors for severe COVID-19 infection
    Kadiyska, Tanya
    Cherneva, Radostina
    Cherneva, Zheina
    Marchev, Sotir
    Madzharova, Dilyana
    Tourtourikov, Ivan
    Mitev, Vanyo
    PHARMACIA, 2024, 71 : 1 - 8
  • [22] Clozapine treatment and risk of severe COVID-19 infection
    Ohlis, Anna
    Wallin, Alma Sorberg
    Sarafis, Anna
    Sjoqvist, Hugo
    MacCabe, James H.
    Ahlen, Johan
    Dalman, Christina
    ACTA PSYCHIATRICA SCANDINAVICA, 2022, 145 (01) : 79 - 85
  • [23] Dexamethasone in severe COVID-19 infection: A case series
    Hassan, Mohamed Eliwa
    Hasan, Hasan M. S. N.
    Sridharan, Kannan
    Elkady, Adel
    ElSeirafi, Mohamed M. A.
    RESPIRATORY MEDICINE CASE REPORTS, 2020, 31
  • [24] Severe arterial thrombosis associated with Covid-19 infection
    Kashi, Mahine
    Jacquin, Aurelien
    Dakhil, Bassel
    Zaimi, Rym
    Mahe, Emmanuel
    Tella, Emilie
    Bagan, Patrick
    THROMBOSIS RESEARCH, 2020, 192 : 75 - 77
  • [25] Hypocalcemia in COVID-19: Prevalence, clinical significance and therapeutic implications
    di Filippo, Luigi
    Doga, Mauro
    Frara, Stefano
    Giustina, Andrea
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2022, 23 (02) : 299 - 308
  • [26] High Prevalence of Hypocalcemia in Non-severe COVID-19 Patients: A Retrospective Case-Control Study
    Pal, Rimesh
    Ram, Sant
    Zohmangaihi, Deepy
    Biswas, Indranil
    Suri, Vikas
    Yaddanapudi, Laxmi N.
    Malhotra, Pankaj
    Soni, Shiv L.
    Puri, Goverdhan D.
    Bhalla, Ashish
    Bhadada, Sanjay K.
    FRONTIERS IN MEDICINE, 2021, 7
  • [27] Leukemoid Reaction in a Patient With Severe COVID-19 Infection
    Tarekegn, Kidist
    Ramos, Ana Colon
    Gross, Harry G. Sequeira
    Yu, Ming
    Fulger, Ilmana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
  • [28] Potential neurological effects of severe COVID-19 infection
    Nuzzo, Domenico
    Picone, Pasquale
    NEUROSCIENCE RESEARCH, 2020, 158 : 1 - 5
  • [29] Primary thromboprophylaxis in a patient with type 3 von Willebrand disease and severe COVID-19 infection
    Vagrecha, Anshul
    Stanco, Joseph
    Majeed, Sumreen
    Kouides, Peter
    Acharya, Suchitra S.
    HAEMOPHILIA, 2021, 27 (04) : E517 - E519
  • [30] Risk factors for severe COVID-19 infection and the impact of COVID-19 infection on disease progression among patients with AAV
    Wang, Chen
    Li, Zhi-Ying
    Jiang, Gui-Ping
    Zhao, Ming-Hui
    Chen, Min
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
12345